Literature DB >> 2574683

TCGF III/P40 is produced by naive murine CD4+ T cells but is not a general T cell growth factor.

E Schmitt1, R Van Brandwijk, J Van Snick, B Siebold, E Rüde.   

Abstract

Several antigen-specific T cell lines were found to secrete a lymphokine upon activation by antigen or lectin that was provisionally termed T cell growth factor III (TCGF III) because it induced the proliferation of a CD4+ T cell clone independently from IL2 and IL4. Amino acid sequence analysis (and the functional properties of TCGF III) revealed that TCGF III was identical with a recently identified lymphokine termed P40. TCGF III/P40 was not only produced by long-term cultured T cell lines but also upon stimulation of freshly isolated Mlsa-reactive T cells. In addition, naive CD4+ T cells secreted TCGF III/P40 upon activation by lectin or allo-major histocompatibility complex structures. However, in spite of its growth-promoting activity for a CD4+ T cell clone this lymphokine does not appear to function as a general growth factor for T cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574683     DOI: 10.1002/eji.1830191130

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  30 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

Review 3.  Discovery and initial characterization of Th9 cells: the early years.

Authors:  Edgar Schmitt; Tobias Bopp
Journal:  Semin Immunopathol       Date:  2016-11-28       Impact factor: 9.623

Review 4.  A brief history of IL-9.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2011-03-15       Impact factor: 5.422

5.  Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells.

Authors:  Matthias Klein; Till-Julius Brühl; Valérie Staudt; Sebastian Reuter; Nadine Grebe; Bastian Gerlitzki; Markus Hoffmann; Toszka Bohn; Alexander Ulges; Natascha Stergiou; Jos de Graaf; Martin Löwer; Christian Taube; Marc Becker; Tobias Hain; Sarah Dietzen; Michael Stassen; Magdalena Huber; Michael Lohoff; Andrezza Campos Chagas; John Andersen; Jan Kotál; Helena Langhansová; Jan Kopecký; Hansjörg Schild; Michalis Kotsyfakis; Edgar Schmitt; Tobias Bopp
Journal:  J Immunol       Date:  2015-06-15       Impact factor: 5.422

6.  The many lives of IL-9: a question of survival?

Authors:  Christoph Wilhelm; Jan-Eric Turner; Jacques Van Snick; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2012-06-19       Impact factor: 25.606

Review 7.  The dichotomous function of interleukin-9 in cancer diseases.

Authors:  K Gerlach; B Weigmann
Journal:  J Mol Med (Berl)       Date:  2019-08-08       Impact factor: 4.599

8.  Autocrine release of interleukin-9 promotes Jak3-dependent survival of ALK+ anaplastic large-cell lymphoma cells.

Authors:  Lin Qiu; Raymond Lai; Quan Lin; Esther Lau; David M Thomazy; Daniel Calame; Richard J Ford; Larry W Kwak; Robert A Kirken; Hesham M Amin
Journal:  Blood       Date:  2006-06-08       Impact factor: 22.113

Review 9.  Th9 cells in inflammatory bowel diseases.

Authors:  Benno Weigmann; Markus F Neurath
Journal:  Semin Immunopathol       Date:  2016-11-11       Impact factor: 9.623

10.  Interleukin-9 stimulates the proliferation of enriched human erythroid progenitor cells: additive effect with GM-CSF.

Authors:  M R Schaafsma; J H Falkenburg; N Duinkerken; J Van Snick; J E Landegent; R Willemze; W E Fibbe
Journal:  Ann Hematol       Date:  1993-01       Impact factor: 3.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.